Events & Presentations
Upcoming Events
| Date | Event Details | Remind Me |
|---|---|---|
|
Sep 26, 2023 10:30 AM EDT
|
2023 Cantor Fitzgerald Global Healthcare Conference
|
Archived Events
| Date | Event Details |
|---|---|
|
Jun 13 - Jun 16, 2022
|
Goldman Sachs 43rd Annual Global Healthcare Conference
Type: Fireside chat presentation
Presenter: Vincent Anzalone, Vice President Finance and Investor Relations, Arrowhead Pharmaceuticals |
|
Jun 8, 2022 8:30 AM EDT
|
Jefferies Healthcare Conference
Type: Fireside chat presentation
Presenter: Vincent Anzalone, Vice President Finance and Investor Relations, Arrowhead Pharmaceuticals |
|
May 26, 2022 10:00 AM EDT
|
Pulmonary R&D Day
View Presentation 16.6 MB
New York
|
|
May 25, 2022 12:15 PM EDT
|
UBS Global Healthcare Conference 2022
Type: Fireside chat presentation
Presenter: Vincent Anzalone, Vice President Finance and Investor Relations, Arrowhead Pharmaceuticals |
|
May 17, 2022 4:35 PM EDT
|
2022 RBC Capital Markets Global Healthcare Conference
Type: Fireside chat presentation
Presenter: Christopher Anzalone, President and CEO, Arrowhead Pharmaceuticals |
|
May 13 - May 18, 2022
|
2022 American Thoracic Society (ATS) International Conference
ATS 2022 MUC5AC 2 MB
ATS 2022 RAGE 2.2 MB
Title: Silencing RAGE Expression with a Lung-Targeted RNAi Trigger Delivery Platform Suppresses Pulmonary Allergic Inflammation
Presenter: David Kasahara, Senior Scientist III, Biology, Arrowhead Pharmaceuticals Title: Silencing Muc5ac Expression with a Lung-Targeted RNAi Trigger Prevents Allergen-Induced Mucoobstruction and Airway Hyperresponsiveness Presenter: David Kasahara, Senior Scientist III, Biology, Arrowhead Pharmaceuticals |
|
May 12, 2022 1:40 PM EDT
|
BofA Securities 2022 Healthcare Conference
Type: Fireside chat presentation
Presenter: Christopher Anzalone, President and CEO, Arrowhead Pharmaceuticals |
|
May 10, 2022 4:30 PM EDT
|
Arrowhead Pharmaceuticals 2022 Second Quarter Results
Prepared Remarks 260.5 KB
|
|
May 9 - May 12, 2022
|
TIDES USA 2022: Oligonucleotide and Peptide Therapeutics
View Presentation 3.5 MB
Title: Arrowhead’s Approach to Oligonucleotide Scale-Up Manufacturing
Presenter: Michael Lawler, Director, Chemistry, Arrowhead Pharmaceuticals |
|
Apr 25 - Apr 27, 2022
|
DIA/FDA's Oligonucleotide-based Therapeutics Conference (Oligo22)
DIA FDA 2022 ARO-HIF2 2.2 MB
Title: Short Interfering RNA JNJ-3989 Combination Therapy Title: ARO-HIF2 Evaluated in Clear Cell Renal Cell Carcinoma Ph1b Clinical Trial |